Atrovent Nasal Spray official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. 2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE FLOVENT HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in Customize dosing for ATROVENT HFA (ipratropium bromide HFA) Inhalation Aerosol, a maintenance treatment for COPD. View safety and prescribing information. 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VENTOLIN HFA safely and effectively. FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE ATROVENT HFA Inhalation Aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm. How ATROVENT HFA (ipratropium bromide HFA) Inhalation Aerosol, a maintenance treatment for COPD, can help. View safety and prescribing information. See full prescribing information for XOPENEX HFA ®. Adverse reaction information concerning XOPENEX HFA in adults and adolescents is derived from two 8-week, multicenter, randomized, double-blind, active- and placebo-controlled trials in 748 adult and adolescent patients with asthma that compared XOPENEX HFA, a marketed albuterol HFA inhaler, and an HFA-134a placebo inhaler. Table 1 lists. Atrovent HFA Inhalation Aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. In this study, both Atrovent® HFA (ipratropium bromide HFA) Inhalation Aerosol and Atrovent® (ipratropium bromide) Inhalation Aerosol CFC formulations were equally effective in patients over 65 years of age and under 65 years of age. ATROVENT HFA (ipratropium bromide HFA) Inhalation Aerosol should be used with caution in patients with narrow-angle glaucoma, prostatic hypertrophy or bladder-neck obstruction. Information for Patients.